Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Improving patients' outcomes & fragmented specialized care through a connected & advanced Multidisciplinary-Cardio-Metabolic-Clinic

Project description

Integrated care for patients with multiple conditions

Cardiometabolic diseases, including hypertension, diabetes, obesity, heart failure and coronary artery disease, affect millions of people in Europe and are among the leading causes of death and disability. Patients often live with multiple coexisting conditions and frequently receive fragmented, disconnected care that fails to address their complex needs. Digital technologies and AI offer new opportunities to integrate and personalise cardiometabolic care. The EU-funded IMPACT-MED project is developing a comprehensive, people-centred multidisciplinary care framework supported by a digital ecosystem combining AI-based risk stratification, remote monitoring, predictive algorithms and advanced imaging. This framework will be validated through four clinical use cases. The goal is to empower patients, guide clinicians and support more continuous, personalised cardiometabolic disease management.

Objective

Cardiometabolic diseases—hypertension (HTN), obesity, type 1 and 2 diabetes (T1DM, T2DM), coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and heart valve disease (HVD)—often coexist, are diagnosed late, and are among the leading causes of death and disability in Europe, accounting for over 4 million deaths annually and creating major clinical and economic burdens. Multimorbid patients face fragmented care due to disconnected pathways, unequal access, and lack of integration, personalization, proactivity, and digital support. IMPACT-MED addresses these gaps by designing, developing, and deploying an innovative, scalable, and people-centred Multidisciplinary Cardio-Metabolic Care (MCMC) framework, supported by a clinically enriched digital ecosystem combining mature (TRL>8) and innovative (TRL>5) technologies and services. It aims to build productive public-private collaboration, overcoming fragmented and siloed solutions, and preventing institution- or industry-driven models, ultimately enabling a people-centred continuum of care tailored to patients’ capacity (low, moderate, high) in suffering, coping, and managing cardiometabolic conditions. This transformative model supports proactive, continuous care through integrated health solutions such as AI-based risk stratification, predictive algorithms, remote monitoring, advanced imaging, and patient-centred data collection tools. Four use cases (UC1: AI-based BP management; UC2: remote monitoring post-MI; UC3: T1DM self-management; UC4: T2DM phenotyping and care) will operationalize and validate the MCMC models. The framework will empower patients, guide clinicians, optimize pathways, and support continuous disease management. IMPACT-MED will deliver a robust MCMC framework and share with the MCMC community an observatory dashboard with validated expansion and sustainability guidelines and a regulatory strategy to ensure long-term success and global scalability.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-JU-RIA - HORIZON JU Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-JU-IHI-2025-09-single-stage

See all projects funded under this call

Coordinator

UNIVERSITA CAMPUS BIO MEDICO DI ROMA
Net EU contribution
€ 441 500,00
Address
VIA ALVARO DEL PORTILLO 21
00128 Roma
Italy
Region
Centro (IT) Lazio Roma
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 441 500,00

Participants (24)

Partners (1)